Role of Nrf2 in the pathogenesis of atherosclerosis

Free Radical Biology and Medicine

Volumn 88, Issue Part B, 2015, Pages 221-232

  Mimura, Junsei ^a   Itoh, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; CD36; Endothelial cell; Inflammation; Lipid metabolism; Macrophage; Nrf2; Oxidative stress; Oxidized LDL; Smooth muscle cell

Indexed keywords

4 HYDROXYNONENAL; ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; CD163 ANTIGEN; CD36 ANTIGEN; CHOLESTEROL; CRYOPYRIN; ELECTROPHILE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; AORTA ATHEROSCLEROSIS; ARTERY INJURY; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIUM CELL; FAMILIAL HYPERCHOLESTEROLEMIA; FOAM CELL; GENE INACTIVATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC BACKGROUND; GENETICALLY ENGINEERED MOUSE STRAIN; GLUTATHIONE METABOLISM; HUMAN; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; POLARIZATION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE CELL; WHITE ADIPOSE TISSUE; ANIMAL; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; HUMANS; MICE; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 84971281708     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.019     Document Type: Review

References (165)

1. A.J. Lusis, R. Mar, and P. Pajukanta Genetics of atherosclerosis Annu Rev Genomics Hum Genet 5 2004 189 218
2. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
3. M. Rafieian-Kopaei, M. Setorki, M. Doudi, A. Baradaran, and H. Nasri Atherosclerosis: process, indicators, risk factors and new hopes Int J Prev Med 5 2014 927 946
4. F. Bonomini, S. Tengattini, A. Fabiano, R. Bianchi, and R. Rezzani Atherosclerosis and oxidative stress Histol. Histopathol. 23 2008 381 390
5. V.M. Victor, M. Rocha, E. Solá, C. Bañuls, K. Garcia-Malpartida, and A. Hernández-Mijares Oxidative stress, endothelial dysfunction and atherosclerosis Curr. Pharm. Des 15 2009 2988 3002
6. M. Mudau, A. Genis, A. Lochner, and H. Strijdom Endothelial dysfunction: the early predictor of atherosclerosis Cardiovasc J Afr 23 2012 222 231
7. K.J. Woollard, and F. Geissmann Monocytes in atherosclerosis: subsets and functions Nat Rev Cardiol 7 2010 77 86
8. T. Gui, A. Shimokado, Y. Sun, T. Akasaka, and Y. Muragaki Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery Mediators Inflamm. 2012 2012 693083
9. A. Rudijanto The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis Acta Med Indones 39 2007 86 93
10. A.C. Doran, N. Meller, and C.A. McNamara Role of smooth muscle cells in the initiation and early progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 28 2008 812 819
11. A.K. Jain, and A.K. Jaiswal GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2 J. Biol. Chem. 282 2007 16502 16510
12. S.K. Niture, A.K. Jain, P.M. Shelton, and A.K. Jaiswal Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression J. Biol. Chem. 286 2011 28821 28832
13. P. Rada, A.I. Rojo, S. Chowdhry, M. McMahon, J.D. Hayes, and A. Cuadrado SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner Mol. Cell. Biol. 31 2011 1121 1133
14. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, and J.D. Hayes Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity Oncogene 32 2013 3765 3781
15. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc. Natl. Acad. Sci. U.S.A. 97 2000 12475 12480
16. H.-C. Huang, T. Nguyen, and C.B. Pickett Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription J. Biol. Chem. 277 2002 42769 42774
17. L.M. Zipper, and R.T. Mulcahy Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells Toxicol. Sci. 73 2003 124 134
18. S.B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, and J.A. Diehl Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209
19. S.B. Cullinan, and J.A. Diehl PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress J. Biol. Chem. 279 2004 20108 20117
20. L.M. Zipper, and R.T. Mulcahy Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes Biochem. Biophys. Res. Commun. 278 2000 484 492
21. A.N. Kong, E. Owuor, R. Yu, V. Hebbar, C. Chen, R. Hu, and S. Mandlekar Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE) Drug Metab. Rev. 33 2001 255 271
22. J. Li, T. Ichikawa, J.S. Janicki, and T. Cui Targeting the Nrf2 pathway against cardiovascular disease Expert Opin. Ther. Targets 13 2009 785 794
23. R. Howden Nrf2 and cardiovascular defense Oxid Med Cell Longev 2013 2013 104308
24. A.A. Gupte, C.J. Lyon, and W.A. Hsueh Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis Curr. Diab. Rep 13 2013 362 371
25. F.R. Kapourchali, G. Surendiran, L. Chen, E. Uitz, B. Bahadori, and M.H. Moghadasian Animal models of atherosclerosis World J Clin Cases 2 2014 126 132
26. W.C. Dornas, T.T. Oliveira, L.E.F. de; Augusto, and T.J. Nagem Experimental atherosclerosis in rabbits Arq. Bras. Cardiol. 95 2010 272 278
27. J. Fan, S. Kitajima, T. Watanabe, J. Xu, J. Zhang, E. Liu, and Y.E. Chen Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine Pharmacol. Ther. 146 2015 104 119
28. S.C. Whitman A practical approach to using mice in atherosclerosis research Clin Biochem Rev 25 2004 81 93
29. J. Jawień, P. Nastałek, and R. Korbut Mouse models of experimental atherosclerosis J. Physiol. Pharmacol. 55 2004 503 517
30. A. Roberts, and J.S. Thompson Inbred mice and their hypbrids as an animal model for atherosclerosis research Adv. Exp. Med. Biol. 67 1976 313 327
31. S.H. Zhang, R.L. Reddick, J.A. Piedrahita, and N. Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science 258 1992 468 471
32. A.S. Plump, J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 71 1992 343 353
33. R.L. Reddick, S.H. Zhang, and N. Maeda Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression Arterioscler. Thromb. 14 1994 141 147
34. S. Ishibashi, M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery J. Clin. Invest. 92 1993 883 893
35. D.A. Sanan, D.L. Newland, R. Tao, S. Marcovina, J. Wang, V. Mooser, R.E. Hammer, and H.H. Hobbs Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a) Proc. Natl. Acad. Sci. U.S.A. 95 1998 4544 4549
36. T.E. Sussan, J. Jun, R. Thimmulappa, D. Bedja, M. Antero, K.L. Gabrielson, V.Y. Polotsky, and S. Biswal Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice PLoS ONE 3 2008 e3791
37. B. Barajas, N. Che, F. Yin, A. Rowshanrad, L.D. Orozco, K.W. Gong, X. Wang, L.W. Castellani, K. Reue, A.J. Lusis, and J.A. Araujo NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection Arterioscler. Thromb. Vasc. Biol. 31 2011 58 66
38. S. Freigang, F. Ampenberger, G. Spohn, S. Heer, A.T. Shamshiev, J. Kisielow, M. Hersberger, M. Yamamoto, M.F. Bachmann, and M. Kopf Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis Eur. J. Immunol. 41 2011 2040 2051
39. N. Harada, K. Ito, T. Hosoya, J. Mimura, A. Maruyama, N. Noguchi, K. Yagami, N. Morito, S. Takahashi, J.M. Maher, M. Yamamoto, and K. Itoh Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation Free Radic. Biol. Med. 53 2012 2256 2262
40. A.R. Collins, A.A. Gupte, R. Ji, M.R. Ramirez, L.J. Minze, J.Z. Liu, M. Arredondo, Y. Ren, T. Deng, J. Wang, C.J. Lyon, and W.A. Hsueh Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury Arterioscler. Thromb. Vasc. Biol. 32 2012 2839 2846
41. A.-K. Ruotsalainen, M. Inkala, M.E. Partanen, J.P. Lappalainen, E. Kansanen, P.I. Mäkinen, S.E. Heinonen, H.M. Laitinen, J. Heikkilä, T. Vatanen, S. Hörkkö, M. Yamamoto, S. Ylä-Herttuala, M. Jauhiainen, and A.-L. Levonen The absence of macrophage Nrf2 promotes early atherogenesis Cardiovasc. Res. 98 2013 107 115
42. T. Ishii, K. Itoh, E. Ruiz, D.S. Leake, H. Unoki, M. Yamamoto, and G.E. Mann Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal Circ. Res. 94 2004 609 616
43. A. Maruyama, S. Tsukamoto, K. Nishikawa, A. Yoshida, N. Harada, K. Motojima, T. Ishii, A. Nakane, M. Yamamoto, and K. Itoh Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements Arch. Biochem. Biophys. 477 2008 139 145
44. S.H. Juan, T.S. Lee, K.W. Tseng, J.Y. Liou, S.K. Shyue, K.K. Wu, and L.Y. Chau Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice Circulation 104 2001 1519 1525
45. S.-F. Yet, M.D. Layne, X. Liu, Y.-H. Chen, B. Ith, N.E.S. Sibinga, and M.A. Perrella Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling FASEB J 17 2003 1759 1761
46. L.D. Orozco, M.H. Kapturczak, B. Barajas, X. Wang, M.M. Weinstein, J. Wong, J. Deshane, S. Bolisetty, Z. Shaposhnik, D.M. Shih, A. Agarwal, A.J. Lusis, and J.A. Araujo Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis Circ. Res. 100 2007 1703 1711
47. C. Cheng, A.M. Noordeloos, V. Jeney, M.P. Soares, F. Moll, G. Pasterkamp, P.W. Serruys, and H.J. Duckers Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque Circulation 119 2009 3017 3027
48. T. Hayek, J. Oiknine, J.G. Brook, and M. Aviram Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice Biochem. Biophys. Res. Commun. 201 1994 1567 1574
49. I. Maor, M. Kaplan, T. Hayek, J. Vaya, A. Hoffman, and M. Aviram Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols Biochem. Biophys. Res. Commun. 269 2000 775 780
50. S.K. Biswas, D.E. Newby, I. Rahman, and I.L. Megson Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E(-/-) mice Biochem. Biophys. Res. Commun. 338 2005 1368 1373
51. M. Rosenblat, R. Coleman, and M. Aviram Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice Atherosclerosis 163 2002 17 28
52. M. Rosenblat, N. Volkova, R. Coleman, and M. Aviram Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice Atherosclerosis 195 2007 e61 e68
53. A. Callegari, Y. Liu, C.C. White, A. Chait, P. Gough, E.W. Raines, D. Cox, T.J. Kavanagh, and M.E. Rosenfeld Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 31 2011 2473 2482
54. S. Cho, M. Hazama, Y. Urata, S. Goto, S. Horiuchi, K. Sumikawa, and T. Kondo Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells Free Radic. Biol. Med. 26 1999 589 602
55. F. Bea, F.N. Hudson, A. Chait, T.J. Kavanagh, and M.E. Rosenfeld Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements Circ. Res. 92 2003 386 393
56. M. Qiao, M. Kisgati, J.M. Cholewa, W. Zhu, E.J. Smart, M.S. Sulistio, and R. Asmis Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 1375 1382
57. M. Torzewski, V. Ochsenhirt, A.L. Kleschyov, M. Oelze, A. Daiber, H. Li, H. Rossmann, S. Tsimikas, K. Reifenberg, F. Cheng, H.-A. Lehr, S. Blankenberg, U. Förstermann, T. Münzel, and K.J. Lackner Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 850 857
58. P. Lewis, N. Stefanovic, J. Pete, A.C. Calkin, S. Giunti, V. Thallas-Bonke, K.A. Jandeleit-Dahm, T.J. Allen, I. Kola, M.E. Cooper, and J.B. de Haan Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice Circulation 115 2007 2178 2187
59. J. Kisucka, A.K. Chauhan, I.S. Patten, A. Yesilaltay, C. Neumann, R.A. Van Etten, M. Krieger, and D.D. Wagner Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis Circ. Res. 103 2008 598 605
60. J.-G. Park, J.-Y. Yoo, S.-J. Jeong, J.-H. Choi, M.-R. Lee, M.-N. Lee, J. Hwa Lee, H.C. Kim, H. Jo, D.-Y. Yu, S.W. Kang, S.G. Rhee, M.-H. Lee, and G.T. Oh Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice Circ. Res. 109 2011 739 749
61. J. Huang, I. Tabbi-Anneni, V. Gunda, and L. Wang Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G1211 G1221
62. T. Karasawa, A. Takahashi, R. Saito, M. Sekiya, M. Igarashi, H. Iwasaki, S. Miyahara, S. Koyasu, Y. Nakagawa, K. Ishii, T. Matsuzaka, K. Kobayashi, N. Yahagi, K. Takekoshi, H. Sone, S. Yatoh, H. Suzuki, N. Yamada, and H. Shimano Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 31 2011 1788 1795
63. M.J. Kim, K.J. Lee, J.-Y. Hwang, H.S. Lee, S.H. Chio, S. Lim, H.C. Jang, and Y.J. Park Loss of small heterodimer partner protects against atherosclerosis in apolipoprotein E-deficient mice Endocr. J. 60 2013 1171 1177
64. S.-Y. Kim, N.H. Jeoung, C.J. Oh, Y.-K. Choi, H.-J. Lee, H.-J. Kim, J.-Y. Kim, J.H. Hwang, S. Tadi, Y.-H. Yim, K.-U. Lee, K.-G. Park, S. Huh, K.-N. Min, K.-H. Jeong, M.G. Park, T.H. Kwak, G.R. Kweon, K. Inukai, M. Shong, and I.-K. Lee Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation Circ. Res. 104 2009 842 850
65. R. Sugimoto, E. Warabi, S. Katayanagi, S. Sakai, J. Uwayama, T. Yanagawa, A. Watanabe, H. Harada, K. Kitamura, N. Noguchi, H. Yoshida, R.C.M. Siow, G.E. Mann, and T. Ishii Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice J. Cell. Mol. Med. 14 2010 1546 1554
66. J.-M. Li, and A.M. Shah Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology Am. J. Physiol. Regul. Integr. Comp. Physiol 287 2004 R1014 R1030
67. T. Kondo, M. Hirose, and K. Kageyama Roles of oxidative stress and redox regulation in atherosclerosis J. Atheroscler. Thromb. 16 2009 532 538
68. H.-J. Hsieh, C.-A. Liu, B. Huang, A.H. Tseng, and D.L. Wang Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications J. Biomed. Sci. 21 2014 3
69. G.E. Mann, J. Niehueser-Saran, A. Watson, L. Gao, T. Ishii, P. de Winter, and R.C. Siow Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia Sheng Li Xue Bao 59 2007 117 127
70. X.-L. Chen, G. Dodd, S. Thomas, X. Zhang, M.A. Wasserman, B.H. Rovin, and C. Kunsch Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression Am. J. Physiol. Heart Circ. Physiol 290 2006 H1862 H1870
71. J. Kim, Y.-N. Cha, and Y.-J. Surh A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders Mutat. Res. 690 2010 12 23
72. M.N. Valcarcel-Ares, T. Gautam, J.P. Warrington, L. Bailey-Downs, D. Sosnowska, R. de Cabo, G. Losonczy, W.E. Sonntag, Z. Ungvari, and A. Csiszar Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 821 829
73. Y. Wei, J. Gong, R.K. Thimmulappa, B. Kosmider, S. Biswal, and E.J. Duh Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching Proc. Natl. Acad. Sci. U.S.A. 110 2013 E3910 E3918
74. H.-O. Pae, G.-S. Oh, B.-S. Lee, J.-S. Rim, Y.-M. Kim, and H.-T. Chung 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells Atherosclerosis 187 2006 274 284
75. X.-L. Chen, G. Dodd, and C. Kunsch Sulforaphane inhibits TNF-alpha-induced activation of p38 MAP kinase and VCAM-1 and MCP-1 expression in endothelial cells Inflamm. Res. 58 2009 513 521
76. H. Zhang, F. Zheng, J. Zhao, D. Guo, and X. Chen Genistein inhibits ox-LDL-induced VCAM-1, ICAM-1 and MCP-1 expression of HUVECs through heme oxygenase-1 Arch. Med. Res. 44 2013 13 20
77. T. Hosoya, A. Maruyama, M.-I. Kang, Y. Kawatani, T. Shibata, K. Uchida, E. Warabi, N. Noguchi, K. Itoh, and M. Yamamoto Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells J. Biol. Chem. 280 2005 27244 27250
78. E. Warabi, W. Takabe, T. Minami, K. Inoue, K. Itoh, M. Yamamoto, T. Ishii, T. Kodama, and N. Noguchi Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species Free Radic. Biol. Med. 42 2007 260 269
79. G. Dai, S. Vaughn, Y. Zhang, E.T. Wang, G. Garcia-Cardena, and M.A. Gimbrone Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2 Circ. Res. 101 2007 723 733
80. C.-Y. Hsieh, H.-Y. Hsiao, W.-Y. Wu, C.-A. Liu, Y.-C. Tsai, Y.-J. Chao, D.L. Wang, and H.-J. Hsieh Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells J. Biomed. Sci. 16 2009 12
81. W. Takabe, E. Warabi, and N. Noguchi Anti-atherogenic effect of laminar shear stress via Nrf2 activation Antioxid. Redox Signal. 15 2011 1415 1426
82. K.S. Schneider, and J.Y. Chan Emerging role of Nrf2 in adipocytes and adipose biology Adv Nutr 4 2013 62 66
83. Z. Zhang, S. Zhou, X. Jiang, Y.-H. Wang, F. Li, Y.-G. Wang, Y. Zheng, and L. Cai The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome Rev Endocr Metab Disord 16 2015 35 45
84. H.-A. Seo, and I.-K. Lee The role of Nrf2: adipocyte differentiation, obesity, and insulin resistance Oxid Med Cell Longev 2013 184598 2013
85. Y. Tanaka, L.M. Aleksunes, R.L. Yeager, M.A. Gyamfi, N. Esterly, G.L. Guo, and C.D. Klaassen NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet J. Pharmacol. Exp. Ther. 325 2008 655 664
86. N.R. Kitteringham, A. Abdullah, J. Walsh, L. Randle, R.E. Jenkins, R. Sison, C.E.P. Goldring, H. Powell, C. Sanderson, S. Williams, L. Higgins, M. Yamamoto, J. Hayes, and B.K. Park Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver J Proteomics 73 2010 1612 1631
87. S. Shin, J. Wakabayashi, M.S. Yates, N. Wakabayashi, P.M. Dolan, S. Aja, K.T. Liby, M.B. Sporn, M. Yamamoto, and T.W. Kensler Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide Eur. J. Pharmacol. 620 2009 138 144
88. Y.-K.J. Zhang, R.L. Yeager, Y. Tanaka, and C.D. Klaassen Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet Toxicol. Appl. Pharmacol. 245 2010 326 334
89. J. Xu, S.R. Kulkarni, A.C. Donepudi, V.R. More, and A.L. Slitt Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice Diabetes 61 2012 3208 3218
90. J. Xu, A.C. Donepudi, J.E. Moscovitz, and A.L. Slitt Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissue PLoS ONE 8 2013 e79841
91. S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G.H. Lee, E.S. Agoston, M. Yamamoto, and T.W. Kensler Nrf2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis Mol. Cell. Biol. 27 2007 7188 7197
92. T. Takahashi, T. Tabuchi, Y. Tamaki, K. Kosaka, Y. Takikawa, and T. Satoh Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism Biochem. Biophys. Res. Commun. 382 2009 549 554
93. J. Pi, L. Leung, P. Xue, W. Wang, Y. Hou, D. Liu, E. Yehuda-Shnaidman, C. Lee, J. Lau, T.W. Kurtz, and J.Y. Chan Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity J. Biol. Chem. 285 2010 9292 9300
94. P. Xue, Y. Hou, Y. Chen, B. Yang, J. Fu, H. Zheng, K. Yarborough, C.G. Woods, D. Liu, M. Yamamoto, Q. Zhang, M.E. Andersen, and J. Pi Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome Diabetes 62 2013 845 854
95. J. Xu, A.C. Donepudi, V.R. More, S.R. Kulkarni, L. Li, L. Guo, B. Yan, T. Chatterjee, N. Weintraub, and A.L. Slitt Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice Obesity (Silver Spring) 23 2015 335 344
96. Y. Hou, P. Xue, Y. Bai, D. Liu, C.G. Woods, K. Yarborough, J. Fu, Q. Zhang, G. Sun, S. Collins, J.Y. Chan, M. Yamamoto, M.E. Andersen, and J. Pi Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis Free Radic. Biol. Med. 52 2012 462 472
97. M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 105 2000 1049 1056
98. M. Febbraio, D.P. Hajjar, and R.L. Silverstein CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism J. Clin. Invest. 108 2001 785 791
99. S. Kuchibhotla, D. Vanegas, D.J. Kennedy, E. Guy, G. Nimako, R.E. Morton, and M. Febbraio Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II Cardiovasc. Res. 78 2008 185 196
100. H. Sawada, Y. Saito, and N. Noguchi Enhanced CD36 expression changes the role of Nrf2 activation from anti-atherogenic to pro-atherogenic in apoE-deficient mice Atherosclerosis 225 2012 83 90
101. Y. Hernandez-Trujillo, F. Rodriguez-Esparragon, A. Macias-Reyes, A. Caballero-Hidalgo, and J.C. Rodriguez-Perez Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model Cardiovasc Diabetol 7 2008 3
102. H. Suzuki, Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O. Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsumoto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, and T. Kodama A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection Nature 386 1997 292 296
103. W.J. De Villiers, and E.J. Smart Macrophage scavenger receptors and foam cell formation J. Leukoc. Biol. 66 1999 740 746
104. T.J. Van Berkel, M. Van Eck, N. Herijgers, K. Fluiter, and S. Nion Scavenger receptor classes A and B. Their roles in atherogenesis and the metabolism of modified LDL and HDL Ann. N. Y. Acad. Sci 902 2000 113 126 discussion 126-127
105. A. Baldán, L. Pei, R. Lee, P. Tarr, R.K. Tangirala, M.M. Weinstein, J. Frank, A.C. Li, P. Tontonoz, and P.A. Edwards Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow Arterioscler. Thromb. Vasc. Biol. 26 2006 2301 2307
106. M. Ranalletta, N. Wang, S. Han, L. Yvan-Charvet, C. Welch, and A.R. Tall Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow Arterioscler. Thromb. Vasc. Biol. 26 2006 2308 2315
107. L. Yvan-Charvet, M. Ranalletta, N. Wang, S. Han, N. Terasaka, R. Li, C. Welch, and A.R. Tall Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice J. Clin. Invest. 117 2007 3900 3908
108. W. Lin, R.T. Wu, T. Wu, T.-O. Khor, H. Wang, and A.-N. Kong Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway Biochem. Pharmacol. 76 2008 967 973
109. X. Kong, R. Thimmulappa, P. Kombairaju, and S. Biswal NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice J. Immunol. 185 2010 569 577
110. A.-M. Kuhn, N. Tzieply, M.V. Schmidt, A. von Knethen, D. Namgaladze, M. Yamamoto, and B. Brüne Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages Free Radic. Biol. Med. 50 2011 1382 1391
111. A.R. Collins, C.J. Lyon, X. Xia, J.Z. Liu, R.K. Tangirala, F. Yin, R. Boyadjian, A. Bikineyeva, D. Praticò, D.G. Harrison, and W.A. Hsueh Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes Circ. Res. 104 2009 e42 e54
112. C. Mo, L. Wang, J. Zhang, S. Numazawa, H. Tang, X. Tang, X. Han, J. Li, M. Yang, Z. Wang, D. Wei, and H. Xiao The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice Antioxid. Redox Signal. 20 2014 574 588
113. J. Khallou-Laschet, A. Varthaman, G. Fornasa, C. Compain, A.-T. Gaston, M. Clement, M. Dussiot, O. Levillain, S. Graff-Dubois, A. Nicoletti, and G. Caligiuri Macrophage plasticity in experimental atherosclerosis PLoS ONE 5 2010 e8852
114. N. Leitinger, and I.G. Schulman Phenotypic polarization of macrophages in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 33 2013 1120 1126
115. F. De Paoli, B. Staels, and G. Chinetti-Gbaguidi Macrophage phenotypes and their modulation in atherosclerosis Circ. J. 78 2014 1775 1781
116. S. Colin, G. Chinetti-Gbaguidi, and B. Staels Macrophage phenotypes in atherosclerosis Immunol. Rev. 262 2014 153 166
117. C.A. Gleissner, I. Shaked, K.M. Little, and K. Ley CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages J. Immunol. 184 2010 4810 4818
118. C.A. Gleissner, I. Shaked, C. Erbel, D. Böckler, H.A. Katus, and K. Ley CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages Circ. Res. 106 2010 203 211
119. J.J. Boyle, H.A. Harrington, E. Piper, K. Elderfield, J. Stark, R.C. Landis, and D.O. Haskard Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype Am. J. Pathol. 174 2009 1097 1108
120. J.J. Boyle, M. Johns, T. Kampfer, A.T. Nguyen, L. Game, D.J. Schaer, J.C. Mason, and D.O. Haskard Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection Circ. Res. 110 2012 20 33
121. A.V. Finn, M. Nakano, R. Polavarapu, V. Karmali, O. Saeed, X. Zhao, S. Yazdani, F. Otsuka, T. Davis, A. Habib, J. Narula, F.D. Kolodgie, and R. Virmani Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques J. Am. Coll. Cardiol. 59 2012 166 177
122. A. Kadl, A.K. Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, S.R. Johnstone, M.R. Elliott, F. Gruber, J. Han, W. Chen, T. Kensler, K.S. Ravichandran, B.E. Isakson, B.R. Wamhoff, and N. Leitinger Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ. Res. 107 2010 737 746
123. C. Smith, M.J. Mitchinson, O.I. Aruoma, and B. Halliwell Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions Biochem. J. 286 Pt 3 1992 901 905
124. T.S. Lee, M.S. Shiao, C.C. Pan, and L.Y. Chau Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice Circulation 99 1999 1222 1229
125. J.L. Sullivan Iron in arterial plaque: modifiable risk factor for atherosclerosis Biochim. Biophys. Acta 1790 2009 718 723
126. F. Vinchi, M.U. Muckenthaler, M.C. Da Silva, G. Balla, J. Balla, and V. Jeney Atherogenesis and iron: from epidemiology to cellular level Front Pharmacol 5 2014 94
127. S. Recalcati, M. Locati, A. Marini, P. Santambrogio, F. Zaninotto, M. De Pizzol, L. Zammataro, D. Girelli, and G. Cairo Differential regulation of iron homeostasis during human macrophage polarized activation Eur. J. Immunol. 40 2010 824 835
128. G. Cairo, S. Recalcati, A. Mantovani, and M. Locati Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype Trends Immunol. 32 2011 241 247
129. N. Harada, M. Kanayama, A. Maruyama, A. Yoshida, K. Tazumi, T. Hosoya, J. Mimura, T. Toki, J.M. Maher, M. Yamamoto, and K. Itoh Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages Arch. Biochem. Biophys. 508 2011 101 109
130. G. Bories, S. Colin, J. Vanhoutte, B. Derudas, C. Copin, M. Fanchon, M. Daoudi, L. Belloy, S. Haulon, C. Zawadzki, B. Jude, B. Staels, and G. Chinetti-Gbaguidi Liver X receptor activation stimulates iron export in human alternative macrophages Circ. Res. 113 2013 1196 1205
131. S. Singh, S. Vrishni, B.K. Singh, I. Rahman, and P. Kakkar Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases Free Radic. Res. 44 2010 1267 1288
132. J.C. Leemans, S.L. Cassel, and F.S. Sutterwala Sensing damage by the NLRP3 inflammasome Immunol. Rev. 243 2011 152 162
133. D. De Nardo, and E. Latz NLRP3 inflammasomes link inflammation and metabolic disease Trends Immunol. 32 2011 373 379
134. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nuñez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, and E. Latz NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
135. K. Rajamäki, J. Lappalainen, K. Oörni, E. Välimäki, S. Matikainen, P.T. Kovanen, and K.K. Eklund Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation PLoS ONE 5 2010 e11765
136. F.J. Sheedy, A. Grebe, K.J. Rayner, P. Kalantari, B. Ramkhelawon, S.B. Carpenter, C.E. Becker, H.N. Ediriweera, A.E. Mullick, D.T. Golenbock, L.M. Stuart, E. Latz, K.A. Fitzgerald, and K.J. Moore CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation Nat. Immunol. 14 2013 812 820
137. F. Zheng, S. Xing, Z. Gong, W. Mu, and Q. Xing Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice Mediators Inflamm. 2014 2014 507208
138. P. Menu, M. Pellegrin, J.-F. Aubert, K. Bouzourene, A. Tardivel, L. Mazzolai, and J. Tschopp Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome Cell Death Dis 2 2011 e137
139. C. Oury CD36: linking lipids to the NLRP3 inflammasome, atherogenesis and atherothrombosis Cell. Mol. Immunol. 11 2014 8 10
140. C. Zhao, D.D. Gillette, X. Li, Z. Zhang, and H. Wen Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation J. Biol. Chem. 289 2014 17020 17029
141. P. Lacolley, V. Regnault, A. Nicoletti, Z. Li, and J.-B. Michel The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles Cardiovasc. Res. 95 2012 194 204
142. J.J. Boyle Vascular smooth muscle cell apoptosis in atherosclerosis Int J Exp Pathol 80 1999 197 203
143. K.K. Griendling, and M. Ushio-Fukai Redox control of vascular smooth muscle proliferation J. Lab. Clin. Med. 132 1998 9 15
144. Y. Taniyama, and K.K. Griendling Reactive oxygen species in the vasculature: molecular and cellular mechanisms Hypertension 42 2003 1075 1081
145. R.M. Touyz, and E.L. Schiffrin Reactive oxygen species in vascular biology: implications in hypertension Histochem. Cell Biol 122 2004 339 352
146. A.-L. Levonen, M. Inkala, T. Heikura, S. Jauhiainen, H.-K. Jyrkkänen, E. Kansanen, K. Määttä, E. Romppanen, P. Turunen, J. Rutanen, and S. Ylä-Herttuala Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo Arterioscler. Thromb. Vasc. Biol. 27 2007 741 747
147. T. Ashino, M. Yamamoto, T. Yoshida, and S. Numazawa Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia Arterioscler. Thromb. Vasc. Biol. 33 2013 760 768
148. H.J. Duckers, M. Boehm, A.L. True, S.F. Yet, H. San, J.L. Park, R. Clinton Webb, M.E. Lee, G.J. Nabel, and E.G. Nabel Heme oxygenase-1 protects against vascular constriction and proliferation Nat. Med 7 2001 693 698
149. C. Cheng, R.A. Haasdijk, D. Tempel, W.K. den Dekker, I. Chrifi, L.A.J. Blonden, E.H.M. van de Kamp, M. de Boer, P.E. Bürgisser, A. Noorderloos, J.A.P. Rens, T.L.M. ten Hagen, and H.J. Duckers PDGF-induced migration of vascular smooth muscle cells is inhibited by heme oxygenase-1 via VEGFR2 upregulation and subsequent assembly of inactive VEGFR2/PDGFRβ heterodimers Arterioscler. Thromb. Vasc. Biol. 32 2012 1289 1298
150. F.-M. Ho, H.-C. Kang, S.-T. Lee, Y. Chao, Y.-C. Chen, L.-J. Huang, and W.-W. Lin The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells Biochem. Pharmacol. 74 2007 298 308
151. S. Magesh, Y. Chen, and L. Hu Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents Med Res Rev 32 2012 687 726
152. T. Suzuki, H. Motohashi, and M. Yamamoto Toward clinical application of the Keap1-Nrf2 pathway Trends Pharmacol. Sci. 34 2013 340 346
153. H. Kumar, I.-S. Kim, S.V. More, B.-W. Kim, and D.-K. Choi Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases Nat Prod Rep 31 2014 109 139
154. M.-K. Kwak, N. Wakabayashi, and T.W. Kensler Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers Mutat. Res. 555 2004 133 148
155. B.M. Hybertson, B. Gao, S.K. Bose, and J.M. McCord Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation Mol. Aspects Med. 32 2011 234 246
156. Y. Ding, B. Zhang, K. Zhou, M. Chen, M. Wang, Y. Jia, Y. Song, Y. Li, and A. Wen Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation Int. J. Cardiol. 175 2014 508 514
157. J.-S. Chen, P.-H. Huang, C.-H. Wang, F.-Y. Lin, H.-Y. Tsai, T.-C. Wu, S.-J. Lin, and J.-W. Chen Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract Atherosclerosis 214 2011 301 309
158. K.Y. Hur, S.H. Kim, M.-A. Choi, D.R. Williams, Y. Lee, S.W. Kang, U.C.S. Yadav, S.K. Srivastava, M. Jung, J.W. Cho, S.G. Kim, E.S. Kang, E.J. Lee, and H.C. Lee Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway Atherosclerosis 211 2010 69 76
159. N. Zghonda, S. Yoshida, M. Araki, M. Kusunoki, A. Mliki, A. Ghorbel, and H. Miyazaki Greater effectiveness of ϵ-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration Biosci. Biotechnol. Biochem. 75 2011 1259 1267
160. X.J. Wang, J.D. Hayes, C.J. Henderson, and C.R. Wolf Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha Proc. Natl. Acad. Sci. U.S.A. 104 2007 19589 19594
161. D. Ren, N.F. Villeneuve, T. Jiang, T. Wu, A. Lau, H.A. Toppin, and D.D. Zhang Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism Proc. Natl. Acad. Sci. U.S.A. 108 2011 1433 1438
162. X. Tang, H. Wang, L. Fan, X. Wu, A. Xin, H. Ren, and X.J. Wang Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs Free Radic. Biol. Med. 50 2011 1599 1609
163. S.M. Figarska, J.M. Vonk, and H.M. Boezen NFE2L2 polymorphisms, mortality, and metabolism in the general population Physiol. Genomics 46 2014 411 417
164. M. Siedlinski, D.S. Postma, J.M.A. Boer, G. van der Steege, J.P. Schouten, H.A. Smit, and H.M. Boezen Level and course of FEV1 in relation to polymorphisms in NFE2L2 and Keap1 in the general population Respir. Res. 10 2009 73
165. J.M. Marzec, J.D. Christie, S.P. Reddy, A.E. Jedlicka, H. Vuong, P.N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H.-Y. Cho, and S.R. Kleeberger Functional polymorphisms in the transcription factor Nrf2 in humans increase the risk of acute lung injury FASEB J 21 2007 2237 2246